The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment

[1]  Shaghayegh Haghjooy Javanmard,et al.  Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies , 2020, Cancer Cell International.

[2]  M. Rashidi,et al.  Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells. , 2020, European journal of pharmacology.

[3]  G. Deep,et al.  Hypoxia in tumor microenvironment regulates exosome biogenesis: Molecular mechanisms and translational opportunities. , 2020, Cancer letters.

[4]  Yang Guo,et al.  MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma , 2020, Biological Research.

[5]  Wei Zhang,et al.  MiR-200a Regulates Nasopharyngeal Carcinoma Cell Migration and Invasion by Targeting MYH10 , 2020, Journal of Cancer.

[6]  Yau-Huei Wei,et al.  Targeting cancer stem cells from a metabolic perspective , 2020, Experimental biology and medicine.

[7]  Haifeng Liu,et al.  The protective effects of microRNA-26a in steroid-induced osteonecrosis of the femoral head by repressing EZH2 , 2020, Cell cycle.

[8]  Wen Peng,et al.  Targeting cancer stem cell pathways for cancer therapy , 2020, Signal Transduction and Targeted Therapy.

[9]  Mamdouh M. Ali,et al.  Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles , 2020, Molecules.

[10]  H. Mirzaei,et al.  New trends in glioma cancer therapy: Targeting Na+/H + exchangers , 2020, Journal of cellular physiology.

[11]  M. Ohmichi,et al.  MicroRNA-22 enhances radiosensitivity in cervical cancer cell lines via direct inhibition of c-Myc binding protein, and the subsequent reduction in hTERT expression , 2020, Oncology letters.

[12]  Yuanyuan Qin,et al.  NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer , 2020, Theranostics.

[13]  Jun Zhao,et al.  SNHG1 promotes MPP+-induced cytotoxicity by regulating PTEN/AKT/mTOR signaling pathway in SH-SY5Y cells via sponging miR-153-3p , 2020, Biological Research.

[14]  A. Gure,et al.  A Stemness and EMT Based Gene Expression Signature Identifies Phenotypic Plasticity and is A Predictive but Not Prognostic Biomarker for Breast Cancer , 2020, Journal of Cancer.

[15]  Tao Yang,et al.  Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells , 2020, Journal of Cancer.

[16]  Mohammad Aslam Khan,et al.  Hypoxia alters the release and size distribution of extracellular vesicles in pancreatic cancer cells to support their adaptive survival , 2020, Journal of cellular biochemistry.

[17]  Longyuan Wu,et al.  microRNA: The Impact on Cancer Stemness and Therapeutic Resistance , 2019, Cells.

[18]  H. Becker.  Carbonic anhydrase IX and acid transport in cancer , 2019, British Journal of Cancer.

[19]  S. Mohapatra,et al.  Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma , 2019, Front. Immunol..

[20]  B. Boone,et al.  Neutrophil extracellular traps in breast cancer and beyond: current perspectives on NET stimuli, thrombosis and metastasis, and clinical utility for diagnosis and treatment , 2019, Breast Cancer Research.

[21]  M. Najafi,et al.  Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance , 2019, Journal of Cancer Research and Clinical Oncology.

[22]  Isobel S Okoye,et al.  Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. , 2019, Life sciences.

[23]  C. Piccoli,et al.  Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications , 2019, Oxidative medicine and cellular longevity.

[24]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[25]  L. Qin,et al.  Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment , 2019, Front. Oncol..

[26]  F. Staud,et al.  Are ENT1/ENT1, NOTCH3, and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy? , 2019, Cancers.

[27]  A. Coulibaly,et al.  Interleukin-15 Signaling in HIF-1α Regulation in Natural Killer Cells, Insights Through Mathematical Models , 2019, Front. Immunol..

[28]  R. Abdi,et al.  T Regulatory Cells and Priming the Suppressive Tumor Microenvironment , 2019, Front. Immunol..

[29]  Q. Hao,et al.  LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer , 2019, OncoTargets and therapy.

[30]  C. Bousquet,et al.  Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression , 2019, International journal of molecular sciences.

[31]  K. Alfarouk,et al.  Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies , 2019, International journal of molecular sciences.

[32]  Y. Shah,et al.  Hypoxic Regulation of Neutrophils in Cancer , 2019, International journal of molecular sciences.

[33]  G. Toffoli,et al.  New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma , 2019, Cancers.

[34]  Christopher J. Lyon,et al.  Tumor‐derived exosomes (TDEs): How to avoid the sting in the tail , 2019, Medicinal research reviews.

[35]  Yong Li,et al.  Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression , 2019, BMC Cancer.

[36]  F. Watt,et al.  Mechanisms, Hallmarks, and Implications of Stem Cell Quiescence , 2019, Stem cell reports.

[37]  J. Foley,et al.  Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumors , 2019, BMC Cancer.

[38]  N. Desai,et al.  Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects , 2019, Stem Cell Reviews and Reports.

[39]  A. Poggi,et al.  Functional Interaction of Hypoxia-Inducible Factor 2-Alpha and Autophagy Mediates Drug Resistance in Colon Cancer Cells , 2019, Cancers.

[40]  Ji-Eun Kim,et al.  Cancer cell–induced neutrophil extracellular traps promote both hypercoagulability and cancer progression , 2019, PloS one.

[41]  I. Astuti,et al.  Upregulation of Circulating MiR-21 Expression as a Potential Biomarker for Therapeutic Monitoring and Clinical Outcome in Breast Cancer , 2019, Asian Pacific journal of cancer prevention : APJCP.

[42]  Chan Kwon Park,et al.  Hypoxia-induced cancer stemness acquisition is associated with CXCR4 activation by its aberrant promoter demethylation , 2019, BMC Cancer.

[43]  N. Forsyth,et al.  Hypoxia-Modified Cancer Cell Metabolism , 2019, Front. Cell Dev. Biol..

[44]  F. Peng,et al.  Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells , 2019, The Journal of clinical investigation.

[45]  Wai Hoong Chang,et al.  Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion , 2019, British Journal of Cancer.

[46]  D. Long,et al.  HIF-1α protects against oxidative stress by directly targeting mitochondria , 2019, Redox biology.

[47]  Zhongchao Zhu,et al.  Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling , 2018, Journal of Experimental & Clinical Cancer Research.

[48]  Yan-bin Zhao,et al.  miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC , 2018, Stem Cell Research & Therapy.

[49]  P. Kuppusamy,et al.  Hyperoxygenation as a Therapeutic Supplement for Treatment of Triple Negative Breast Cancer , 2018, Front. Oncol..

[50]  O. Olopade,et al.  HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways , 2018, Journal of Experimental & Clinical Cancer Research.

[51]  C. Ager,et al.  Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy , 2018, The Journal of clinical investigation.

[52]  A. Carè,et al.  Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules , 2018, Journal of Experimental & Clinical Cancer Research.

[53]  E. Unger,et al.  Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment , 2018, International journal of nanomedicine.

[54]  Hui Zhou,et al.  miR‐372 and miR‐373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways , 2018, Molecular oncology.

[55]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[56]  Ziwei Wang,et al.  miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer , 2018, Cellular Physiology and Biochemistry.

[57]  Tao Xi,et al.  Up‐regulation of miR‐210 induced by a hypoxic microenvironment promotes breast cancer stem cell metastasis, proliferation, and self‐renewal by targeting E‐cadherin , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  E. Rozeman,et al.  Targeting tumor-associated acidity in cancer immunotherapy , 2018, Cancer Immunology, Immunotherapy.

[59]  Bhushan J Toley,et al.  Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics. , 2018, Biotechnology advances.

[60]  Jorge Lima,et al.  Metabolic traits of cancer stem cells , 2018, Disease Models & Mechanisms.

[61]  M. Lai,et al.  Hypoxia‐inducible factor 1α plays a predominantly negative role in regulatory T cell functions , 2018, Journal of leukocyte biology.

[62]  A. Möller,et al.  Intermittent hypoxia induces a metastatic phenotype in breast cancer , 2018, Oncogene.

[63]  T. Lefebvre,et al.  Cross regulation between mTOR signaling and O-GlcNAcylation , 2018, Journal of Bioenergetics and Biomembranes.

[64]  Zhong Yun,et al.  The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells , 2018, Breast Cancer Research.

[65]  Shou-Ching Tang,et al.  Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking , 2018, International journal of molecular medicine.

[66]  R. Deng,et al.  In vitro and in vivo effects of miRNA-19b/20a/92a on gastric cancer stem cells and the related mechanism , 2018, International journal of medical sciences.

[67]  J. Bergh,et al.  An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression , 2017, Cancer cell.

[68]  Elena Butturini,et al.  Metastatic Breast Cancer Cells Enter Into Dormant State and Express Cancer Stem Cells Phenotype Under Chronic Hypoxia , 2017, Journal of cellular biochemistry.

[69]  Ziv Porat,et al.  Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function. , 2017, Cell reports.

[70]  G. Freeman,et al.  Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy. , 2017, Cancer cell.

[71]  I. Ng,et al.  Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma , 2017, Nature Communications.

[72]  D. Lindgren,et al.  CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells. , 2017, Cell reports.

[73]  R. Dina,et al.  Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior , 2017, Oncoimmunology.

[74]  Jeong-Seok Nam,et al.  Roles of Wnt Target Genes in the Journey of Cancer Stem Cells , 2017, International journal of molecular sciences.

[75]  Deric M. Park,et al.  Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells , 2017, Neuro-oncology.

[76]  F. Sotgia,et al.  Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs) , 2017, Oncotarget.

[77]  Fei Su,et al.  Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer. , 2017, Human pathology.

[78]  R. Vij,et al.  Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance , 2017, Leukemia & lymphoma.

[79]  P. V. Bramhachari,et al.  Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer. , 2017, Critical reviews in oncology/hematology.

[80]  E. Tagliabue,et al.  Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation. , 2017, Seminars in cancer biology.

[81]  A. Avan,et al.  Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4 , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[82]  T. Yamashita,et al.  Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells , 2017, Cancer science.

[83]  M. Konopleva,et al.  Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy , 2017, Clinical Cancer Research.

[84]  A. Avan,et al.  Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer , 2016, Cancer Gene Therapy.

[85]  Inkyung Jung,et al.  Epithelial Hypoxia-Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils , 2016, Molecular and Cellular Biology.

[86]  J. Griffiths,et al.  The immunometabolite S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate , 2016, Nature.

[87]  Z. Yao,et al.  Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer , 2016, Oncotarget.

[88]  S. Richard,et al.  Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status. , 2016, European urology.

[89]  I. Ng,et al.  Hypoxia induces myeloid‐derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C‐C motif) ligand 26 , 2016, Hepatology.

[90]  R. Kalluri.  The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[91]  S. Påhlman,et al.  Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. , 2016, Pharmacology & therapeutics.

[92]  Su In Lee,et al.  Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer , 2016, Oncotarget.

[93]  H. Moch,et al.  PD‐L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma , 2016, International journal of cancer.

[94]  R. McKenna,et al.  Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011–2016) , 2016, Expert opinion on therapeutic patents.

[95]  A. Avan,et al.  Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach , 2016, Cancer Gene Therapy.

[96]  Jacques Haiech,et al.  Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy , 2016, Stem cells international.

[97]  Joel s. Brown,et al.  Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces. , 2016, Cancer research.

[98]  C. Balch,et al.  Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells , 2016, Expert opinion on drug metabolism & toxicology.

[99]  J. Vieweg,et al.  Hypoxia regulates SOX2 expression to promote prostate cancer cell invasion and sphere formation. , 2016, American journal of cancer research.

[100]  I. Ng,et al.  Down‐regulation of TIMP2 by HIF‐1α/miR‐210/HIF‐3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma , 2016, Hepatology.

[101]  Sonia Y. Velásquez,et al.  Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities* , 2016, The Journal of Biological Chemistry.

[102]  J. Taube,et al.  Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy , 2016, Nature Reviews Cancer.

[103]  Ning Li,et al.  MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells , 2016, Oncology research.

[104]  P. Vaupel,et al.  Pathophysiological Basis for the Formation of the Tumor Microenvironment , 2016, Front. Oncol..

[105]  S. C. Chafe,et al.  Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction , 2016, Front. Cell Dev. Biol..

[106]  A. Tsung,et al.  Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress. , 2016, Cancer research.

[107]  R. Gillies,et al.  Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy. , 2016, Cancer research.

[108]  V. Gopalan,et al.  Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells , 2016, Biology of the cell.

[109]  K. Mitra,et al.  Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis , 2016, Scientific Reports.

[110]  Michiyasu Suzuki,et al.  Histological Characterization of the Tumorigenic “Peri-Necrotic Niche” Harboring Quiescent Stem-Like Tumor Cells in Glioblastoma , 2016, PloS one.

[111]  Zhao-You Tang,et al.  MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2 , 2016, Journal of Hematology & Oncology.

[112]  S. Dey,et al.  Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells. , 2015, Cancer cell.

[113]  A. Azab,et al.  The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy , 2015, Hypoxia.

[114]  Zhimin Wang,et al.  Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells. , 2015, International journal of molecular medicine.

[115]  H. Shim,et al.  Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions , 2015, Respiratory Research.

[116]  Jeong-Won Lee,et al.  Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma , 2015, Oncotarget.

[117]  F. Martelli,et al.  Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210. , 2015, Cancer research.

[118]  R. Schreiber,et al.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.

[119]  C. Graham,et al.  Mechanisms Of Hypoxia-Induced Immune Escape In Cancer And Their Regulation By Nitric Oxide. , 2015, Redox biology.

[120]  G. Semenza,et al.  Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype , 2015, Proceedings of the National Academy of Sciences.

[121]  Rong-Yu Liu,et al.  Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells , 2015, Scientific Reports.

[122]  A. Harris,et al.  Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition , 2015, Oncotarget.

[123]  A. Weng,et al.  Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling. , 2015, Blood.

[124]  M. Borad,et al.  Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[125]  B. Han,et al.  Wnt blockers inhibit the proliferation of lung cancer stem cells , 2015, Drug design, development and therapy.

[126]  Sigrid A. Langhans,et al.  Cancer as a channelopathy: ion channels and pumps in tumor development and progression , 2015, Front. Cell. Neurosci..

[127]  A. Harris,et al.  Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality , 2015, EMBO molecular medicine.

[128]  S. Jiang,et al.  Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo , 2015, Nature Communications.

[129]  Ronit Vogt Sionov,et al.  Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. , 2015, Cell reports.

[130]  A. Azab,et al.  The role of P-glycoprotein in drug resistance in multiple myeloma , 2015, Leukemia & lymphoma.

[131]  X Wang,et al.  Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis , 2014, Oncogene.

[132]  G. Semenza,et al.  Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells , 2014, Proceedings of the National Academy of Sciences.

[133]  A. Avan,et al.  EGFR as a potential target for the treatment of pancreatic cancer: dilemma and controversies. , 2014, Current drug targets.

[134]  J. Szade,et al.  Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation. , 2014, American journal of translational research.

[135]  P. Horák,et al.  HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells , 2014, Molecular Cancer Research.

[136]  T. Das,et al.  Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop , 2014, Stem Cell Research & Therapy.

[137]  K. Ganjoo,et al.  Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  B. Zhu,et al.  [Quantitation of intestinal Fusobacterium and butyrate- producing bacteria in patients with colorectal adenomas and colorectal cancer]. , 2014, Wei sheng wu xue bao = Acta microbiologica Sinica.

[139]  G. Cline,et al.  Functional polarization of tumour-associated macrophages by tumour-derived lactic acid , 2014, Nature.

[140]  A. Adjei,et al.  Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer. , 2014, Cancer treatment reviews.

[141]  J. Markowitz,et al.  ABC Transporters in Multi-Drug Resistance and ADME-Tox of Small Molecule Tyrosine Kinase Inhibitors , 2014, Pharmaceutical Research.

[142]  P. Dessen,et al.  PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation , 2014, The Journal of experimental medicine.

[143]  Bo Ri Seo,et al.  In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. , 2014, Advanced drug delivery reviews.

[144]  I. B. Borel Rinkes,et al.  Hypoxia After Liver Surgery Imposes an Aggressive Cancer Stem Cell Phenotype on Residual Tumor Cells , 2014, Annals of surgery.

[145]  Hong Liao,et al.  The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor. , 2014, The international journal of biochemistry & cell biology.

[146]  Florian Lang,et al.  Ion channels in cancer: future perspectives and clinical potential , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[147]  A. Schwab,et al.  Ion channels and transporters in tumour cell migration and invasion , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[148]  J. Gong,et al.  HIF-1α and HIF-2α: Siblings in Promoting Angiogenesis of Residual Hepatocellular Carcinoma after High-Intensity Focused Ultrasound Ablation , 2014, PloS one.

[149]  Yun Lu,et al.  SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1α-dependent glycolysis. , 2014, Cancer research.

[150]  R. Nemenoff,et al.  Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. , 2014, Immunity.

[151]  M. Mazzone,et al.  Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. , 2013, Cancer cell.

[152]  P. Pandolfi,et al.  miR-22 in tumorigenesis , 2013, Cell cycle.

[153]  S. C. Chafe,et al.  Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche , 2013, Oncogene.

[154]  P. Muranski,et al.  Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. , 2013, The Journal of clinical investigation.

[155]  E. Yang,et al.  Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen , 2013, Nature Immunology.

[156]  Fang Wang,et al.  MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells , 2013, Journal of Cell Science.

[157]  Ugo Ala,et al.  MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling , 2013, Cell.

[158]  U. Karsten,et al.  What makes cancer stem cell markers different? , 2013, SpringerPlus.

[159]  S. Gerecht,et al.  Hypoxia Affects the Structure of Breast Cancer Cell-Derived Matrix to Support Angiogenic Responses of Endothelial Cells , 2013, Journal of carcinogenesis & mutagenesis.

[160]  S. Ahn,et al.  High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α. , 2013, Cancer letters.

[161]  P. Benos,et al.  Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3 , 2013, Proceedings of the National Academy of Sciences.

[162]  Shu-Chun Lin,et al.  MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance , 2013, Current opinion in otolaryngology & head and neck surgery.

[163]  C. Kang,et al.  Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. , 2013, Oncology reports.

[164]  N. Wu,et al.  MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis , 2013, PloS one.

[165]  M. Mimeault,et al.  Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells , 2013, Journal of cellular and molecular medicine.

[166]  R. Cardone,et al.  Na+-H+ exchanger, pH regulation and cancer. , 2012, Recent patents on anti-cancer drug discovery.

[167]  B. Bao,et al.  Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment , 2012, PloS one.

[168]  T. Hagemann,et al.  The tumor microenvironment at a glance , 2012, Journal of Cell Science.

[169]  B. Bao,et al.  The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. , 2012, Biochimica et biophysica acta.

[170]  Chi-Ying F. Huang,et al.  Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. , 2012, American journal of respiratory and critical care medicine.

[171]  B. Bao,et al.  Targeting CSC-related miRNAs for cancer therapy by natural agents. , 2012, Current drug targets.

[172]  W. Biernat,et al.  Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer , 2012, Journal of Translational Medicine.

[173]  D. Ballon,et al.  Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: From bedside to bench , 2012, Journal of Clinical Neuroscience.

[174]  M. Hiraoka,et al.  Microenvironments and Cellular Characteristics in the Micro Tumor Cords of Malignant Solid Tumors , 2012, International journal of molecular sciences.

[175]  D. Schadendorf,et al.  Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth , 2012, The Journal of experimental medicine.

[176]  E. Giannoni,et al.  Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. , 2012, Cancer research.

[177]  E. Clambey,et al.  Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa , 2012, Proceedings of the National Academy of Sciences.

[178]  G. Powis,et al.  Passing the baton: the HIF switch. , 2012, Trends in biochemical sciences.

[179]  Meeri N. Kim,et al.  Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes. , 2012, The Journal of clinical investigation.

[180]  Shadan Ali,et al.  Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM , 2012, PloS one.

[181]  S. Mohanam,et al.  Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells , 2012, PloS one.

[182]  T. Cotechini,et al.  Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide. , 2011, Cancer research.

[183]  B. Krock,et al.  Hypoxia-induced angiogenesis: good and evil. , 2011, Genes & cancer.

[184]  D. Larsimont,et al.  Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations , 2011, Oncogene.

[185]  Theodoros N. Teknos,et al.  microRNA-107 functions as a candidate tumor suppressor gene in head and neck squamous cell carcinoma by down-regulation of protein kinase Cε , 2011, Oncogene.

[186]  Jhi-Joung Wang,et al.  Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. , 2011, Oncology reports.

[187]  J. Pouysségur,et al.  CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors , 2011, Proceedings of the National Academy of Sciences.

[188]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation , 2011, Proceedings of the National Academy of Sciences.

[189]  Lixin Wei,et al.  Epithelial-Mesenchymal Transition in tumor microenvironment , 2011, Cell & Bioscience.

[190]  Matthew P. Jacobson,et al.  Dysregulated pH: a perfect storm for cancer progression , 2011, Nature Reviews Cancer.

[191]  R. Hu,et al.  HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway , 2011, Cell Death and Differentiation.

[192]  M. Keating,et al.  Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells , 2011, The Journal of Biological Chemistry.

[193]  Lin Zhang,et al.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells , 2011, Nature.

[194]  H. Aburatani,et al.  Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. , 2011, Cancer research.

[195]  W. Wilson,et al.  Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.

[196]  T. Cramer,et al.  Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[197]  Yangde Zhang,et al.  Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells , 2011, Molecular and Cellular Biochemistry.

[198]  B. Jiang,et al.  MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression , 2011, PloS one.

[199]  Donglei Liu,et al.  MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2 , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[200]  M. Dean,et al.  Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development , 2011, Clinical pharmacology and therapeutics.

[201]  Agnieszka Pastuła,et al.  Myeloid‐derived suppressor cells: a double‐edged sword? , 2011, International journal of experimental pathology.

[202]  Liu Feng,et al.  Vascular Endothelial Growth Factor Receptor-1 Activation Mediates Epithelial to Mesenchymal Transition in Hepatocellular Carcinoma Cells , 2011, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[203]  L. Vermeulen,et al.  Cancer stem cell niche: the place to be. , 2011, Cancer research.

[204]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[205]  D. Siemann,et al.  The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents. , 2011, Cancer treatment reviews.

[206]  Jun Li,et al.  An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. , 2010, Gynecologic oncology.

[207]  T. Padhya,et al.  HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment , 2010, The Journal of experimental medicine.

[208]  L. Nguyen,et al.  Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody , 2010, Molecular Cancer Therapeutics.

[209]  E. Rofstad,et al.  Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination , 2010, International journal of cancer.

[210]  L. Coussens,et al.  Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. , 2010, Cancer research.

[211]  S. Lyle,et al.  Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance , 2010, Journal of oncology.

[212]  Tian Yang,et al.  microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity , 2010, British Journal of Cancer.

[213]  Zhiwei Wang,et al.  Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells , 2010, PloS one.

[214]  C. Schmitt,et al.  Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB , 2010, PloS one.

[215]  P. Gimotty,et al.  Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. , 2010, The Journal of clinical investigation.

[216]  A. Russo,et al.  miR‐20b modulates VEGF expression by targeting HIF‐1α and STAT3 in MCF‐7 breast cancer cells , 2010, Journal of cellular physiology.

[217]  J. Mackey,et al.  Metabolic Modulation of Glioblastoma with Dichloroacetate , 2010, Science Translational Medicine.

[218]  Zhiwei Wang,et al.  Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. , 2010, Cancer research.

[219]  R. Hruban,et al.  P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis , 2010, Proceedings of the National Academy of Sciences.

[220]  H. Vogel,et al.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. , 2010, The Journal of clinical investigation.

[221]  Jeffrey E. Green,et al.  VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. , 2010, Experimental cell research.

[222]  Qun Chen,et al.  microRNA-181b targets MLK2 in HL-60 cells , 2010, Science China Life Sciences.

[223]  G. Beluffi,et al.  The impact of tumor biology on cancer treatment and multidisciplinary strategies , 2010, La radiologia medica.

[224]  Philippe Lambin,et al.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.

[225]  K. Eckardt,et al.  The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia , 2009, The Journal of Biological Chemistry.

[226]  David A. Gough,et al.  Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[227]  J. Pouysségur,et al.  Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer , 2009, Journal of cellular and molecular medicine.

[228]  K. Ghoshal,et al.  TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 , 2009, Oncogene.

[229]  J. Engh,et al.  Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α , 2009, Oncogene.

[230]  G. Cheng,et al.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.

[231]  K. Nathanson,et al.  HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses , 2009, Proceedings of the National Academy of Sciences.

[232]  Zhiwei Wang,et al.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. , 2009, Cancer research.

[233]  G. Melillo,et al.  Development of HIF-1 inhibitors for cancer therapy , 2009, Journal of cellular and molecular medicine.

[234]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[235]  M. Simon,et al.  Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. , 2009, Blood.

[236]  P. Vaupel,et al.  Tumor hypoxia and malignant progression. , 2009, Methods in enzymology.

[237]  K. Ohuchida,et al.  MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance , 2009, Molecular Cancer Therapeutics.

[238]  D. Hedley,et al.  Cancer stem cells, hypoxia and metastasis. , 2009, Seminars in radiation oncology.

[239]  Mircea Ivan,et al.  MicroRNA regulation of DNA repair gene expression in hypoxic stress. , 2009, Cancer research.

[240]  Jianjun Chen,et al.  miR-21 plays a pivotal role in gastric cancer pathogenesis and progression , 2008, Laboratory Investigation.

[241]  Junxia Zhang,et al.  hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells , 2008, Brain Research.

[242]  G. Koren,et al.  Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction , 2008, Stem cells.

[243]  T. Brabletz,et al.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.

[244]  Xin Wang,et al.  Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells , 2008, Cancer Gene Therapy.

[245]  M. Simon,et al.  The role of oxygen availability in embryonic development and stem cell function , 2008, Nature Reviews Molecular Cell Biology.

[246]  R V Davuluri,et al.  A microRNA component of the hypoxic response , 2008, Cell Death and Differentiation.

[247]  Richard P. Hill,et al.  Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.

[248]  Carme Camps,et al.  hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer , 2008, Clinical Cancer Research.

[249]  T. Suda,et al.  Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche. , 2008, Biochemical and biophysical research communications.

[250]  R. Place,et al.  MicroRNA-373 induces expression of genes with complementary promoter sequences , 2008, Proceedings of the National Academy of Sciences.

[251]  A. Letai,et al.  Diagnosing and exploiting cancer's addiction to blocks in apoptosis , 2008, Nature Reviews Cancer.

[252]  Lin Zhang,et al.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.

[253]  Marianne Koritzinsky,et al.  Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. , 2008, Cancer research.

[254]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.

[255]  I. Tannock,et al.  Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.

[256]  L. Huang,et al.  Hypoxic Suppression of the Cell Cycle Gene CDC25A in Tumor Cells , 2007, Cell cycle.

[257]  D. Hicklin,et al.  Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. , 2007, Cancer research.

[258]  John D Gordan,et al.  HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. , 2007, Cancer cell.

[259]  S. Maddika,et al.  Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[260]  George A. Calin,et al.  A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.

[261]  Wenbin Ye,et al.  MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia , 2006, PloS one.

[262]  V. Grégoire,et al.  Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. , 2006, Cancer research.

[263]  Å. Borg,et al.  Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. , 2006, Cancer cell.

[264]  Anke Sparmann,et al.  Polycomb silencers control cell fate, development and cancer , 2006, Nature Reviews Cancer.

[265]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[266]  A. Halestrap,et al.  The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-regulated by Hypoxia through a HIF-1α-dependent Mechanism* , 2006, Journal of Biological Chemistry.

[267]  Quynh-Thu Le,et al.  Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.

[268]  Brian Keith,et al.  HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. , 2006, Genes & development.

[269]  G. Semenza,et al.  Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. , 2006, Cancer research.

[270]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[271]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[272]  Shuchun Zhao,et al.  Galectin-1: a link between tumor hypoxia and tumor immune privilege. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[273]  M. Sitkovsky,et al.  Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors , 2005, Nature Reviews Immunology.

[274]  P. Schumacker,et al.  Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. , 2005, Cell metabolism.

[275]  S. Colgan,et al.  Inflammatory Hypoxia: Role of Hypoxia-Inducible Factor , 2005, Cell cycle.

[276]  Thomas Hartmann,et al.  Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. , 2004, Cancer cell.

[277]  P. Vaupel,et al.  Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. , 2004, The oncologist.

[278]  Mariël Brok,et al.  Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. , 2004, Blood.

[279]  Nan Tang,et al.  Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis , 2004 .

[280]  C. Lewis,et al.  Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. , 2004, Blood.

[281]  T. Pawlik,et al.  Role of cell cycle in mediating sensitivity to radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[282]  C. Shelley,et al.  Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[283]  L. Huang,et al.  HIF‐1α induces cell cycle arrest by functionally counteracting Myc , 2004 .

[284]  J. Schuetz,et al.  The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme* , 2004, Journal of Biological Chemistry.

[285]  Crispin J. Miller,et al.  Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance , 2004, Molecular and Cellular Biology.

[286]  T. Nikaido,et al.  Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. , 2003, The American journal of pathology.

[287]  E. van Marck,et al.  The Presence of a Fibrotic Focus in Invasive Breast Carcinoma Correlates with the Expression of Carbonic Anhydrase IX and is a Marker of Hypoxia and Poor Prognosis , 2003, Breast Cancer Research and Treatment.

[288]  L. Ellis,et al.  Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. , 2003, The American journal of pathology.

[289]  P. Comoglio,et al.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. , 2003, Cancer cell.

[290]  R. Czekay,et al.  Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins , 2003, The Journal of cell biology.

[291]  Friedo Zölzer,et al.  Increased radiosensitivity with chronic hypoxia in four human tumor cell lines. , 2002, International journal of radiation oncology, biology, physics.

[292]  A. Harris,et al.  Hypoxia‐induced pathways in breast cancer , 2002, Microscopy research and technique.

[293]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[294]  L. Poellinger,et al.  Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[295]  G. Forni,et al.  Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation , 2001, European journal of immunology.

[296]  I. Stratford,et al.  Hypoxia and oxidative stress in breast cancer: Tumour hypoxia – therapeutic considerations , 2001, Breast Cancer Research.

[297]  G. Berx,et al.  The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression , 2001, Breast Cancer Research.

[298]  P. Ratcliffe,et al.  Activation of the HIF pathway in cancer. , 2001, Current opinion in genetics & development.

[299]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[300]  P Vaupel,et al.  Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. , 2001, Seminars in oncology.

[301]  J. Murphy-Ullrich.  The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? , 2001, The Journal of clinical investigation.

[302]  Chi V. Dang,et al.  Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression* , 2001, The Journal of Biological Chemistry.

[303]  M. Ivan,et al.  Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.

[304]  N. Brünner,et al.  The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. , 2000, Cancer research.

[305]  P. Andreasen,et al.  The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.

[306]  I. Fidler,et al.  Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. , 1999, Cancer research.

[307]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[308]  R K Jain,et al.  Geometric Resistance and Microvascular Network Architecture of Human Colorectal Carcinoma , 1997, Microcirculation.

[309]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[310]  D. Hanahan,et al.  Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. , 1996, European journal of cancer.

[311]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[312]  B. Teicher.  Hypoxia and drug resistance , 1994, Cancer and Metastasis Reviews.

[313]  R. Durand.  Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs. , 1991, International journal of radiation oncology, biology, physics.

[314]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[315]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[316]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[317]  G. Fletcher.  Radiation and drug resistance of breast cancer , 1984, American journal of clinical oncology.

[318]  E. Goldmann.  The Growth of Malignant Disease in Man and the Lower Animals, with Special Reference to the Vascular System , 1908 .

[319]  E. Goldmann.  The Growth of Malignant Disease in Man and the Lower Animals, with special reference to the Vascular System. , 1907, Proceedings of the Royal Society of Medicine.

[320]  T. Cotechini,et al.  Hypoxia-Induced Resistance to Chemotherapy in Cancer. , 2019, Advances in experimental medicine and biology.

[321]  Yingchun Li,et al.  LOXL 2 Promotes The Epithelial – Mesenchymal Transition And Malignant Progression Of Cervical Cancer , 2019 .

[322]  J. Cell.  An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression , 2017 .

[323]  J. Griffiths,et al.  S-2-hydroxyglutarate regulates CD 8 + T-lymphocyte fate , 2016 .

[324]  B. Bao,et al.  Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. , 2012, Cancer research.

[325]  G. J. Strijkersb,et al.  Correction for “ CD 147 subunit of lactate / H + symporters MCT 1 and hypoxia-inducible MCT 4 is critical for energetics and growth of glycolytic tumors , 2012 .

[326]  Lu Wang,et al.  MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. , 2011, Cancer research.

[327]  R. Clarke,et al.  Tumor and Stem Cell Biology Cancer Research Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch 4 Receptor , 2010 .

[328]  Danli Wu,et al.  Hypoxic tumors and their effect on immune cells and cancer therapy. , 2010, Methods in molecular biology.

[329]  J. Pouysségur,et al.  Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. , 2009, Cancer research.

[330]  M. Simona,et al.  HIF2 (cid:1) inhibition promotes p53 pathway activity, tumor cell death, and radiation responses , 2009 .

[331]  P. Vaupel,et al.  The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies , 2009 .

[332]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[333]  G. Alpini,et al.  Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[334]  J. Barrett,et al.  HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. , 2004, The EMBO journal.

[335]  Mariël Brok,et al.  Imatinib mesylate ( STI 571 ) is a substrate for the breast cancer resistance protein ( BCRP ) / ABCG 2 drug pump , 2004 .

[336]  J. Schaper,et al.  Regulation of EMAP II by hypoxia. , 2003, The American journal of pathology.

[337]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[338]  R. Rickert,et al.  Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. , 2003, Molecular and cellular biology.

[339]  Oliver Thews,et al.  Treatment resistance of solid tumors , 2001 .

[340]  Å. Borg,et al.  Recruitment of HIF-1 a and HIF-2 a to common target genes is differentially regulated in neuroblastoma : HIF-2 a promotes an aggressive phenotype , 2022 .

[341]  DataSheet_4.zip , 2022 .

[342]  R. Rickert,et al.  Hypoxia-Inducible Factor 1 (cid:2) Is Essential for Cell Cycle Arrest during Hypoxia , 2022 .